Publications by authors named "Ningling Ge"

Claim this Profile
A
AGEs-RAGE manipulates tumor intrinsic pERK/Sp1/IL6 pathway and reprograms macrophage to promote intrahepatic cholangiocarcinoma progression.
Juan Zhang, Biyang Jing, Xiaojian Ni, Youpei Lin, Jiaomeng Pan, Ningling Ge

Transl Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated Multi-Omics Profiling Identifies PDZ-Binding Kinase (PBK) as a Novel Prognostic Biomarker in Hepatocellular Carcinoma.
Juan Zhang, Yingyu Xu, Xiaojian Ni, Zhiyi Mao, Haitao Xiao, Ningling Ge

J Hepatocell Carcinoma· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival in patients with unresectable hepatocellular carcinoma: TCC cocktail plus TACE vs TACE alone prospective randomized clinical trial.
Jie Li, Bei Lv, Li Song, Xingxing Zhang, Jian Zhang, Ningling Ge

J Transl Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of transcatheter arterial chemoembolization-based multimodal treatment in patients with neuroendocrine tumors involving the liver.
Hu Xu, Li Zhang, Juan Zhang, Yi Chen, Ningling Ge

Transl Cancer Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Survey of Clinical Practices for Hepatocellular Carcinoma Among Experts at Tertiary Hospitals in China From 2020 to 2021.
Hong Zhao, Yilei Mao, Hongguang Wang, Aiping Zhou, Zhengqiang Yang, Ningling Ge

Cancer Innov· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison analysis of different doses bevacizumab plus ICIs and interventional therapy in unresectable hepatocellular carcinoma: a real-world study.
Miao Li, Tong Li, Yi Chen, Ningling Ge, Biwei Yang

J Gastrointest Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Morphology of immune-mediated hepatitis: A comparison between immune checkpoint inhibitor therapy and combined immune checkpoint inhibitor/anti-angiogenic therapy.
Qiongyan Zhang, Lingli Chen, Xinxin Guo, Licheng Shen, Yufeng Huang, Ningling Ge

Ann Diagn Pathol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatectomy After Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy for Patients with Unresectable Hepatocellular Carcinoma.
Xiao-Dong Zhu, Cheng Huang, Ying-Hao Shen, Bin Xu, Ning-Ling Ge

Ann Surg Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiographic and α-fetoprotein response predict pathologic complete response to immunotherapy plus a TKI in hepatocellular carcinoma: a multicenter study.
Cheng Huang, Xiao-Dong Zhu, Ying-Hao Shen, Bin Xu, Dong Wu, Ning-Ling Ge

BMC Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study.
Guo-Ming Shi, Xiao-Yong Huang, Dong Wu, Hui-Chuan Sun, Fei Liang, Ning-Ling Ge

Signal Transduct Target Ther· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene-based cancer-testis antigens as prognostic indicators in hepatocellular carcinoma.
Yingyu Xu, Xin Xu, Xiaojian Ni, Jiaomeng Pan, MaoPei Chen, Ningling Ge

Heliyon· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-PD-1 antibodies plus lenvatinib in patients with unresectable hepatocellular carcinoma who progressed on lenvatinib: a retrospective cohort study of real-world patients.
Jixue Zou, Peixin Huang, Ningling Ge, Xin Xu, Yanhong Wang

J Gastrointest Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression and Clinical Significance of MPS-1 in Hepatocellular Carcinoma.
He Jiang, Feifei Yuan, Zhiying Zhao, Tongchun Xue, Ningling Ge

Int J Gen Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic Arterial Infusion Chemotherapy with Modified FOLFOX as an Alternative Treatment Option in Advanced Hepatocellular Carcinoma Patients with Failed or Unsuitability for Transarterial Chemoembolization.
Shu-Jung Hsu, Xin Xu, Mao-Pei Chen, Zhi-Ying Zhao, Yan Wang, Ning-Ling Ge

Acad Radiol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Prognostic Scoring System for Hepatocellular Carcinoma Patients With Main Portal Vein Tumor Thrombus Undergoing Conventional Transarterial Chemoembolization: An Analysis of 173 Patients.
Jing-Huan Li, Xin Yin, Wen-Shuai Fan, Lan Zhang, Rong-Xin Chen, Ning-Ling Ge

Front Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Downstaging and Resection of Initially Unresectable Hepatocellular Carcinoma with Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody Combinations.
Xiao-Dong Zhu, Cheng Huang, Ying-Hao Shen, Yuan Ji, Ning-Ling Ge

Liver Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Organ specific responses to first-line lenvatinib plus anti-PD-1 antibodies in patients with unresectable hepatocellular carcinoma: a retrospective analysis.
Cheng Huang, Xiao-Dong Zhu, Ying-Hao Shen, Dong Wu, Yuan Ji, Ning-Ling Ge

Biomark Res· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new prediction model for prognosis of patients with intermediate-stage HCC after conventional transarterial chemoembolization: an internally validated study.
Rong-Xin Chen, Yu-Hong Gan, Ning-Ling Ge, Yi Chen, Min Ma

J Cancer· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Transarterial Chemoembolization for HBV-Related Hepatocellular Carcinoma After Resection: A Randomized Controlled Study.
Zheng Wang, Zhenggang Ren, Yi Chen, Jie Hu, Guohuan Yang, Ningling Ge

Clin Cancer Res· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis B surface antigen predicts recurrence after radiofrequency ablation in patients with low hepatitis B virus loads.
Lan Zhang, Xiao-Ying Xie, Yi Chen, Ning-Ling Ge, Rong-Xin Chen

Medicine (Baltimore)· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High platelet counts increase metastatic risk in huge hepatocellular carcinoma undergoing transarterial chemoembolization.
Tong-Chun Xue, Ning-Ling Ge, Xin Xu, Fan Le, Bo-Heng Zhang

Hepatol Res· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caveolin-1 Confers Resistance of Hepatoma Cells to Anoikis by Activating IGF-1 Pathway.
Wenqing Tang, Xuemei Feng, Si Zhang, Zhenggang Ren, Yinkun Liu, Ningling Ge

Cell Physiol Biochem· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imbalance in systemic inflammation and immune response following transarterial chemoembolization potentially increases metastatic risk in huge hepatocellular carcinoma.
Tong-Chun Xue, Qing-An Jia, Ning-Ling Ge, Yi Chen, Bo-Heng Zhang

Tumour Biol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The platelet-to-lymphocyte ratio predicts poor survival in patients with huge hepatocellular carcinoma that received transarterial chemoembolization.
Tong-Chun Xue, Qing-An Jia, Ning-Ling Ge, Bo-Heng Zhang, Yan-Hong Wang

Tumour Biol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxaliplatin and 5-fluorouracil hepatic infusion with lipiodolized chemoembolization in large hepatocellular carcinoma.
Jing-Huan Li, Xiao-Ying Xie, Lan Zhang, Fan Le, Ning-Ling Ge

World J Gastroenterol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis